CABENUVA: payments to doctors
Payments that named CABENUVA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $8.1M
- Providers
- 7,091
- Transactions
- 56,413
- Average per transaction
- $144
The per-transaction average — $144 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,091 providers the average total is $1,146, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Viiv Healthcare Company | $8,118,145 | 99.9% |
| Janssen Scientific Affairs, LLC | $3,513 | 0.0% |
| GSK | $720 | 0.0% |
| Janssen Global Services, LLC | $515 | 0.0% |